Company Profile for IntelliChem, Inc.Business Editors --(BUSINESS WIRE) IntelliChem, Inc. is the leading provider of intelligent electronic lab notebooks An electronic lab notebook (also known as Electronic Laboratory Notebook, or ELN) is a software program designed to replace paper laboratory notebooks. Lab notebooks in general are used by scientists and technicians to document research, experiments and procedures performed in a (iELN) for discovery and development. Pharmaceutical, biotechnology, and fine chemicals companies can improve productivity, enable collaboration, improve quality, and ensure regulatory compliance through the adoption of IntelliChem solutions. IntelliChem Discovery & Development Solutions (IDS) were developed and validated val·i·date tr.v. val·i·dat·ed, val·i·dat·ing, val·i·dates 1. To declare or make legally valid. 2. To mark with an indication of official sanction. 3. through partnership with six major pharmaceutical companies, including Merck & Co., Pfizer, and Bristol-Myers Squibb Bristol-Myers Squibb (NYSE: BMY), colloquially referred to as BMS, is a pharmaceutical corporation, formed by a 1989 merger between pharmaceutical companies Bristol-Myers Company, founded in 1887 by William McLaren Bristol and John Ripley Myers in Clinton, NY (both were . IntelliChem is a privately held company privately held company A firm whose shares are held within a relatively small circle of owners and are not traded publicly. with headquarters and development facilities located in Bend, Oregon Bend is a city in Deschutes County, Oregon, United States. The name Bend was derived from "Farewell Bend," the designation used by early pioneers to refer to the location along the Deschutes River where the town eventually was platted, one of the few fordable points along the .
Company: IntelliChem, Inc.
Headquarters Address: 755 SW Bonnett Way
Suite 2100
Bend, OR 97702
Main Telephone: 541-382-7043
Type of Organization: Private
Industry: Technology: Software
Key Executives: CEO: Paul van Eikeren
CFO: Mike Osborn
Investor Relations
Contact: Matt Wallach
Phone: 541-382-7043
Email: matt.wallach@intellichem.com
|
|
|||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion